BioArctic and Eisai sign research evaluation agreement regarding BAN2802 ...Middle East

PR Newswire - News
STOCKHOLM, April 20, 2024 /PRNewswire/ -- BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) today announced that BioArctic AB and Eisai Co., Ltd., have entered into a research evaluation agreement regarding BAN2802, a potential new treatment combining BioArctic's proprietary...

Hence then, the article about bioarctic and eisai sign research evaluation agreement regarding ban2802 was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( BioArctic and Eisai sign research evaluation agreement regarding BAN2802 )

Apple Storegoogle play

Last updated :

Also on site :